Selected research
Industry Research
Chinese Medicine Injection for Nervous Diseases Industry Research Report 2026
Market perspective
The global Chinese Medicine Injection for Nervous Diseases market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Chinese Medicine Injection for Nervous Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Chinese Medicine Injection for Nervous Diseases is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Chinese Medicine Injection for Nervous Diseases is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Chinese Medicine Injection for Nervous Diseases include ZBD Pharmaceutical, Yunnan Biovalley Pharmaceutical, Wuzhou Pharmaceutical, Tasly Pharmaceuticals, Shenyang Shuangding Pharmaceutical, Mudanjiang Youbo Pharmaceutical, Kunming Longjin Pharmaceutical, Kanion Pharmaceutical and Jinling Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Chinese Medicine Injection for Nervous Diseases market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chinese Medicine Injection for Nervous Diseases Market by Company
ZBD Pharmaceutical
Yunnan Biovalley Pharmaceutical
Wuzhou Pharmaceutical
Tasly Pharmaceuticals
Shenyang Shuangding Pharmaceutical
Mudanjiang Youbo Pharmaceutical
Kunming Longjin Pharmaceutical
Kanion Pharmaceutical
Jinling Pharmaceutical
Jemincare
Heilongjiang Wusulijiang Pharmaceutical
Chengdu Baiyu Pharmaceutical
Buchang Pharmaceutical
Chinese Medicine Injection for Nervous Diseases Segment by Type
Xueshuantong Injection (Lyophilized)
Xuesetong Injection (Lyophilized)
Ginkgo Biloba Diterpenoids Meglumine Injection
Xingnaojing Injection
Shuxuetong Injection
Danhong Injection
Acanthopanax Senticosus Injection
Other
Chinese Medicine Injection for Nervous Diseases Segment by Application
Secondary Hospital
Tertiary Hospital
Other
Chinese Medicine Injection for Nervous Diseases Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Injection for Nervous Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Injection for Nervous Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Injection for Nervous Diseases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chinese Medicine Injection for Nervous Diseases manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chinese Medicine Injection for Nervous Diseases by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chinese Medicine Injection for Nervous Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Xueshuantong Injection (Lyophilized)
- Xuesetong Injection (Lyophilized)
- Ginkgo Biloba Diterpenoids Meglumine Injection
- Xingnaojing Injection
- Shuxuetong Injection
- Danhong Injection
- Acanthopanax Senticosus Injection
- Other
Applications
- Secondary Hospital
- Tertiary Hospital
- Other
Companies covered
- ZBD Pharmaceutical
- Yunnan Biovalley Pharmaceutical
- Wuzhou Pharmaceutical
- Tasly Pharmaceuticals
- Shenyang Shuangding Pharmaceutical
- Mudanjiang Youbo Pharmaceutical
- Kunming Longjin Pharmaceutical
- Kanion Pharmaceutical
- Jinling Pharmaceutical
- Jemincare
- Heilongjiang Wusulijiang Pharmaceutical
- Chengdu Baiyu Pharmaceutical
- Buchang Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Chinese Medicine Injection for Nervous Diseases Market Size (2021-2032)
- 2.2.2 Global Chinese Medicine Injection for Nervous Diseases Sales (2021-2032)
- 2.2.3 Global Chinese Medicine Injection for Nervous Diseases Market Average Price (2021-2032)
- 2.3 Chinese Medicine Injection for Nervous Diseases by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Xueshuantong Injection (Lyophilized)
- 2.3.3 Xuesetong Injection (Lyophilized)
- 2.3.4 Ginkgo Biloba Diterpenoids Meglumine Injection
- 2.3.5 Xingnaojing Injection
- 2.3.6 Shuxuetong Injection
- 2.3.7 Danhong Injection
- 2.3.8 Acanthopanax Senticosus Injection
- 2.3.9 Other
- 2.4 Chinese Medicine Injection for Nervous Diseases by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Secondary Hospital
- 2.4.3 Tertiary Hospital
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Chinese Medicine Injection for Nervous Diseases Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Chinese Medicine Injection for Nervous Diseases Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Chinese Medicine Injection for Nervous Diseases Revenue of Manufacturers (2021-2026)
- 3.4 Global Chinese Medicine Injection for Nervous Diseases Average Price by Manufacturers (2021-2026)
- 3.5 Global Chinese Medicine Injection for Nervous Diseases Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Chinese Medicine Injection for Nervous Diseases, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Chinese Medicine Injection for Nervous Diseases, Product Type & Application
- 3.8 Global Manufacturers of Chinese Medicine Injection for Nervous Diseases, Established Date
- 3.9 Global Chinese Medicine Injection for Nervous Diseases Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ZBD Pharmaceutical
- 4.1.1 ZBD Pharmaceutical Company Information
- 4.1.2 ZBD Pharmaceutical Business Overview
- 4.1.3 ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ZBD Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.1.5 ZBD Pharmaceutical Recent Developments
- 4.2 Yunnan Biovalley Pharmaceutical
- 4.2.1 Yunnan Biovalley Pharmaceutical Company Information
- 4.2.2 Yunnan Biovalley Pharmaceutical Business Overview
- 4.2.3 Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yunnan Biovalley Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.2.5 Yunnan Biovalley Pharmaceutical Recent Developments
- 4.3 Wuzhou Pharmaceutical
- 4.3.1 Wuzhou Pharmaceutical Company Information
- 4.3.2 Wuzhou Pharmaceutical Business Overview
- 4.3.3 Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Wuzhou Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.3.5 Wuzhou Pharmaceutical Recent Developments
- 4.4 Tasly Pharmaceuticals
- 4.4.1 Tasly Pharmaceuticals Company Information
- 4.4.2 Tasly Pharmaceuticals Business Overview
- 4.4.3 Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tasly Pharmaceuticals Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.4.5 Tasly Pharmaceuticals Recent Developments
- 4.5 Shenyang Shuangding Pharmaceutical
- 4.5.1 Shenyang Shuangding Pharmaceutical Company Information
- 4.5.2 Shenyang Shuangding Pharmaceutical Business Overview
- 4.5.3 Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shenyang Shuangding Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.5.5 Shenyang Shuangding Pharmaceutical Recent Developments
- 4.6 Mudanjiang Youbo Pharmaceutical
- 4.6.1 Mudanjiang Youbo Pharmaceutical Company Information
- 4.6.2 Mudanjiang Youbo Pharmaceutical Business Overview
- 4.6.3 Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mudanjiang Youbo Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.6.5 Mudanjiang Youbo Pharmaceutical Recent Developments
- 4.7 Kunming Longjin Pharmaceutical
- 4.7.1 Kunming Longjin Pharmaceutical Company Information
- 4.7.2 Kunming Longjin Pharmaceutical Business Overview
- 4.7.3 Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Kunming Longjin Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.7.5 Kunming Longjin Pharmaceutical Recent Developments
- 4.8 Kanion Pharmaceutical
- 4.8.1 Kanion Pharmaceutical Company Information
- 4.8.2 Kanion Pharmaceutical Business Overview
- 4.8.3 Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Kanion Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.8.5 Kanion Pharmaceutical Recent Developments
- 4.9 Jinling Pharmaceutical
- 4.9.1 Jinling Pharmaceutical Company Information
- 4.9.2 Jinling Pharmaceutical Business Overview
- 4.9.3 Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jinling Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.9.5 Jinling Pharmaceutical Recent Developments
- 4.10 Jemincare
- 4.10.1 Jemincare Company Information
- 4.10.2 Jemincare Business Overview
- 4.10.3 Jemincare Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Jemincare Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.10.5 Jemincare Recent Developments
- 4.11 Heilongjiang Wusulijiang Pharmaceutical
- 4.11.1 Heilongjiang Wusulijiang Pharmaceutical Company Information
- 4.11.2 Heilongjiang Wusulijiang Pharmaceutical Business Overview
- 4.11.3 Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Heilongjiang Wusulijiang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.11.5 Heilongjiang Wusulijiang Pharmaceutical Recent Developments
- 4.12 Chengdu Baiyu Pharmaceutical
- 4.12.1 Chengdu Baiyu Pharmaceutical Company Information
- 4.12.2 Chengdu Baiyu Pharmaceutical Business Overview
- 4.12.3 Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Chengdu Baiyu Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.12.5 Chengdu Baiyu Pharmaceutical Recent Developments
- 4.13 Buchang Pharmaceutical
- 4.13.1 Buchang Pharmaceutical Company Information
- 4.13.2 Buchang Pharmaceutical Business Overview
- 4.13.3 Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Buchang Pharmaceutical Chinese Medicine Injection for Nervous Diseases Product Portfolio
- 4.13.5 Buchang Pharmaceutical Recent Developments
5 Global Chinese Medicine Injection for Nervous Diseases Market Scenario by Region
- 5.1 Global Chinese Medicine Injection for Nervous Diseases Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2021-2032
- 5.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2021-2026
- 5.2.2 Global Chinese Medicine Injection for Nervous Diseases Sales by Region: 2027-2032
- 5.3 Global Chinese Medicine Injection for Nervous Diseases Revenue by Region: 2021-2032
- 5.3.1 Global Chinese Medicine Injection for Nervous Diseases Revenue by Region: 2021-2026
- 5.3.2 Global Chinese Medicine Injection for Nervous Diseases Revenue by Region: 2027-2032
- 5.4 North America Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
- 5.4.1 North America Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
- 5.4.3 North America Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
- 5.5.1 Europe Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
- 5.5.3 Europe Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
- 5.6.1 Asia Pacific Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
- 5.7.1 South America Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
- 5.7.3 South America Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Chinese Medicine Injection for Nervous Diseases Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Chinese Medicine Injection for Nervous Diseases Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Chinese Medicine Injection for Nervous Diseases Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Chinese Medicine Injection for Nervous Diseases Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Type (2021-2032)
- 6.1.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Type (2021-2032)
- 6.2 Global Chinese Medicine Injection for Nervous Diseases Revenue by Type (2021-2032)
- 6.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Type (2021-2032)
- 6.3 Global Chinese Medicine Injection for Nervous Diseases Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Application (2021-2032)
- 7.1.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Chinese Medicine Injection for Nervous Diseases Sales Market Share by Application (2021-2032)
- 7.2 Global Chinese Medicine Injection for Nervous Diseases Revenue by Application (2021-2032)
- 7.2.1 Global Chinese Medicine Injection for Nervous Diseases Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Chinese Medicine Injection for Nervous Diseases Revenue Market Share by Application (2021-2032)
- 7.3 Global Chinese Medicine Injection for Nervous Diseases Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Chinese Medicine Injection for Nervous Diseases Value Chain Analysis
- 8.1.1 Chinese Medicine Injection for Nervous Diseases Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Chinese Medicine Injection for Nervous Diseases Production Mode & Process
- 8.2 Chinese Medicine Injection for Nervous Diseases Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Chinese Medicine Injection for Nervous Diseases Distributors
- 8.2.3 Chinese Medicine Injection for Nervous Diseases Customers
9 Global Chinese Medicine Injection for Nervous Diseases Analyzing Market Dynamics
- 9.1 Chinese Medicine Injection for Nervous Diseases Industry Trends
- 9.2 Chinese Medicine Injection for Nervous Diseases Industry Drivers
- 9.3 Chinese Medicine Injection for Nervous Diseases Industry Opportunities and Challenges
- 9.4 Chinese Medicine Injection for Nervous Diseases Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst